National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 634723

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 5/14/2016

VAERS ID: 634723
VAERS Form:
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 9/14/2017

VAERS ID: 634723 Before After
VAERS Form:(blank) 1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 2/14/2018

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 6/14/2018

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 8/14/2018

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 9/14/2018

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 10/14/2018

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 12/24/2020

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 12/30/2020

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 5/7/2021

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.


Changed on 5/21/2021

VAERS ID: 634723 Before After
VAERS Form:1
Age:
Sex:Unknown
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2016-04-12
Entered:2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Fatigue, Injection site pain, Lethargy, Activities of daily living impaired, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016GSK049201

Write-up: This case was reported by a other health professional via sales rep and described the occurrence of lethargy in unspecified number of patients who received BEXSERO. On an unknown date, the patients received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patients experienced lethargy and tiredness. On an unknown date, the outcome of the lethargy and tiredness were recovered/resolved. It was unknown if the reporter considered the lethargy and tiredness to be related to BEXSERO. Additional details received were as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient (see case US2016GSK049200) who received also BEXSERO and experienced a soft-ball like swelling at the injection site. Also mentioned about some other patients concerned in this case who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=634723&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166